Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Soy Treatment for High-risk Women

NCT01219075 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01219075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01219075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Soy Treatment for High-risk Women
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2010
Completion date
November 24, 2022
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation carrier, brca2 mutation carrier, ductal breast carcinoma in situ, lobular breast carcinoma in situ, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer